ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag pharmaceuticals neuroscience

Those We Lost in 2019
Ashley Yeager | Dec 30, 2019 | 6 min read
The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
GPCRs: Researchers Disprove the Single Polypeptide Theory
Jim Kling | Oct 28, 2001 | 5 min read
For this article, Jim Kling interviewed Bryen A. Jordan, postdoctoral scientist in the lab of Edward Ziff at the New York University School of Medicine's department of biochemistry; Theresa Branchek, vice president of research at Synaptic Pharmaceutical Corp. (Paramus, NJ); and Christophe Gerald, vice president of target discovery and assessment at Synaptic Pharmaceutical. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019 | 9 min read
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
RNAs
Drug Discovery Techniques Open the Door to RNA-targeted Drugs
Amber Dance | Jun 1, 2019 | 8 min read
New ways to search for druggable RNAs and matching small molecules
Chemyx: Tracing Fibers - From DiI to Modern Methods
Chemyx Inc. | Apr 24, 2018 | 3 min read
Visualizing neuronal connections is highly important for understanding brain organization and pathophysiology. However, this data has historically been obtained through invasive and often terminal procedures. Technological advances have permitted the development of a new era of neuroanatomical tracing techniques.   
2018 Top 10 Innovations
The Scientist | Dec 1, 2018 | 10+ min read
Biology happens on many levels, from ecosystems to electron transport chains. These tools may help spur discoveries at all of life's scales.
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
Alzheimer Research Joins the Mainstream
Christine Bahls | Jan 20, 2002 | 5 min read
In 1977, Alzheimer Disease researcher Peter Davies spoke with some neurologists about his work, which he began a year earlier. "One [neurologist] said, 'This is lovely..., but why don't you work on something that is more common?'" he remembers. Davies says the comment epitomized scientists' then-dismissive attitude about Alzheimer Disease (AD). When Alois Alzheimer first identified this memory-destroying disorder in 1907, his patient was a 50-year-old woman; a very early age, as researchers now

Run a Search

ADVERTISEMENT